Evidence map›Paper›PMID 33436866›Full record

ArticleScientific reports2021

A novel retinal ganglion cell quantification tool based on deep learning.

Luca Masin, Marie Claes, Steven Bergmans, Lien Cools, Lien Andries, Benjamin M Davis, Lieve Moons, Lies De Groef

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Luca Masin *Department of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Marie Claes *Department of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Steven BergmansDepartment of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Lien CoolsDepartment of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Lien AndriesDepartment of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Benjamin M DavisGlaucoma and Retinal Neurodegenerative Disease Research Group, Institute of Ophthalmology, University College London, London, UK.
Lieve MoonsDepartment of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium.
Lies De GroefDepartment of Biology, Neural Circuit Development and Regeneration Research Group, KU Leuven, Leuven, Belgium. lies.degroef@kuleuven.be.
KU Leuven · BEUK Research and Innovation · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma is a disease associated with the loss of retinal ganglion cells (RGCs), and remains one of the primary causes of blindness worldwide. Major research efforts are presently directed towards the understanding of disease pathogenesis and the development of new therapies, with the help of rodent models as an important preclinical research tool. The ultimate goal is reaching neuroprotection of the RGCs, which requires a tool to reliably quantify RGC survival. Hence, we demonstrate a novel deep learning pipeline that enables fully automated RGC quantification in the entire murine retina. This software, called RGCode (Retinal Ganglion Cell quantification based On DEep learning), provides a user-friendly interface that requires the input of RBPMS-immunostained flatmounts and returns the total RGC count, retinal area and density, together with output images showing the computed counts and isodensity maps. The counting model was trained on RBPMS-stained healthy and glaucomatous retinas, obtained from mice subjected to microbead-induced ocular hypertension and optic nerve crush injury paradigms. RGCode demonstrates excellent performance in RGC quantification as compared to manual counts. Furthermore, we convincingly show that RGCode has potential for wider application, by retraining the model with a minimal set of training data to count FluoroGold-traced RGCs.

Indexed as

Deep LearningSoftwareAnimalsCell CountGlaucomaMiceMice, Inbred C57BLRetinal Ganglion Cells

Identifiers

PMID33436866
PMCPMC7804414
OpenAlexW3118557864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.